505207 Mecamylamine Hydrochloride - CAS 826-39-1 - Calbiochem

505207
View Pricing & Availability

Overview

Replacement Information

Key Specifications Table

Empirical FormulaCAS #
C₁₁H₂₁N•HCl 826-39-1

Pricing & Availability

Catalog Number AvailabilityPackaging Qty/Pack Price Quantity
5.05207.0001
Retrieving availability...
Limited AvailabilityLimited Availability
Stocked 
Discontinued
Limited Quantities Available
Available
    Remaining : Will advise
      Remaining : Will advise
      Will advise
      Contact Customer Service
      Contact Customer Service

      Glass bottle 10 mg
      Retrieving price...
      Price could not be retrieved
      Minimum Quantity needs to be mulitiple of
      Upon Order Completion More Information
      You Saved ()
       
      Request Pricing
      Description
      OverviewA potent, nonselective, and noncompetitive antagonist of nAChRs (IC50 = 640 nM, 2.5 µM, 3.6 µM and 6.9 µM for α3β4, α4β2, α3β2 and α7 subtype nAChRs, respectively). Biologically viable admitted orally or systematically. Widely used in investigating the roles of central nAChRs in the brain functions (learning and memory, decision making, cognition) and disorders (addiction, Autisms, Tourette's syndrome, Schizophrenia and various cognitive and mood disorders).
      Catalogue Number505207
      Brand Family Calbiochem®
      SynonymsN,2,3,3-Tetramethylbicyclo[2.2.1]he­ptan-2-amine hydrochloride, TC-5214, Inversine, nAChR Antagonist, Mecamylamine hydrochloride
      References
      ReferencesHarris, C., et al. 2013. Psychopharmacol. 225, 291.
      Lima, H., et al. 2013. Learning & Memory 20, 120.
      Arnold, E., et al. 2012. J. Child Adolesc. Psychopharmacol. 22, 198.
      Bacher, I., et al. 2009. Expert Opin. Pharmacother. 10, 2709.
      Lippiello, M., et al. 2008. CNS Neurosci. Ther. 14, 266.br>J. M. Young et al. 2001. Clin. Ther. 23, 532.
      Product Information
      CAS number826-39-1
      FormOff-white solid
      Hill FormulaC₁₁H₂₁N•HCl
      Chemical formulaC₁₁H₂₁N•HCl
      ReversibleY
      Structure formula ImageStructure formula Image
      Quality LevelMQ100
      Applications
      Biological Information
      Primary TargetnAChR
      Primary Target IC<sub>50</sub>640 nM
      Purity≥98% by TLC
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      R PhraseR: 25-36/37/38

      Toxic if swallowed.
      Irritating to eyes, respiratory system and skin.
      S PhraseS: 22-26-28.1-36/37/39-46-63

      Do not breathe dust.
      In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.
      After contact with skin, wash immediately with plenty of water.
      Wear suitable protective clothing, gloves and eye/face protection.
      If swallowed, seek medical advice immediately and show this container or label.
      In case of accident by inhalation: remove casualty to fresh air and keep at rest.
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Shipped at Ambient Temperature or with Blue Ice or with Dry Ice
      Toxicity Toxic
      Hazardous Materials Attention: Due to the nature of the Hazardous Materials in this shipment, additional shipping charges may be applied to your order. Certain sizes may be exempt from the additional hazardous materials shipping charges. Please contact your local sales office for more information regarding these charges.
      Storage +2°C to +8°C
      Protect from Light Protect from light
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
      Packaging Information
      Transport Information
      Supplemental Information
      Specifications

      Documentation

      Mecamylamine Hydrochloride - CAS 826-39-1 - Calbiochem SDS

      Title

      Safety Data Sheet (SDS) 

      Mecamylamine Hydrochloride - CAS 826-39-1 - Calbiochem Certificates of Analysis

      TitleLot Number
      505207

      References

      Reference overview
      Harris, C., et al. 2013. Psychopharmacol. 225, 291.
      Lima, H., et al. 2013. Learning & Memory 20, 120.
      Arnold, E., et al. 2012. J. Child Adolesc. Psychopharmacol. 22, 198.
      Bacher, I., et al. 2009. Expert Opin. Pharmacother. 10, 2709.
      Lippiello, M., et al. 2008. CNS Neurosci. Ther. 14, 266.br>J. M. Young et al. 2001. Clin. Ther. 23, 532.
      Data Sheet

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision26-July-2013 JSW
      SynonymsN,2,3,3-Tetramethylbicyclo[2.2.1]he­ptan-2-amine hydrochloride, TC-5214, Inversine, nAChR Antagonist, Mecamylamine hydrochloride
      DescriptionA potent, nonselective, and noncompetitive antagonist of nAChRs (IC50 = 640 nM, 2.5 µM, 3.6 µM and 6.9 µM for α3β4, α4β2, α3β2 and α7 subtype nAChRs, respectively). Biologically viable admitted orally or systematically. Widely used in investigating the roles of central nAChRs in the brain functions (learning and memory, decision making, cognition) and disorders (addiction, Autisms, Tourette's syndrome, Schizophrenia and various cognitive and mood disorders).
      FormOff-white solid
      CAS number826-39-1
      Chemical formulaC₁₁H₂₁N•HCl
      Structure formulaStructure formula
      Purity≥98% by TLC
      SolubilityH₂O (100 mM)
      Storage +2°C to +8°C
      Protect from light
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
      Toxicity Toxic
      ReferencesHarris, C., et al. 2013. Psychopharmacol. 225, 291.
      Lima, H., et al. 2013. Learning & Memory 20, 120.
      Arnold, E., et al. 2012. J. Child Adolesc. Psychopharmacol. 22, 198.
      Bacher, I., et al. 2009. Expert Opin. Pharmacother. 10, 2709.
      Lippiello, M., et al. 2008. CNS Neurosci. Ther. 14, 266.br>J. M. Young et al. 2001. Clin. Ther. 23, 532.